174 related articles for article (PubMed ID: 36861094)
1. Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42.
Medina JI; Cruz-Collazo A; Del Mar Maldonado M; Gascot TM; Borrero-Garcia LD; Cooke M; Kazanietz MG; O'Farril EH; Vlaar CP; Dharmawardhane S
Cancer Res Commun; 2022 Dec; 2(12):1711-1726. PubMed ID: 36861094
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.
Humphries-Bickley T; Castillo-Pichardo L; Hernandez-O'Farrill E; Borrero-Garcia LD; Forestier-Roman I; Gerena Y; Blanco M; Rivera-Robles MJ; Rodriguez-Medina JR; Cubano LA; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2017 May; 16(5):805-818. PubMed ID: 28450422
[TBL] [Abstract][Full Text] [Related]
3. Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.
Torres-Sanchez A; Rivera-Robles M; Castillo-Pichardo L; Martínez-Ferrer M; Dorta-Estremera SM; Dharmawardhane S
Front Oncol; 2023; 13():1152458. PubMed ID: 37397366
[TBL] [Abstract][Full Text] [Related]
4. Development of EHop-016: a small molecule inhibitor of Rac.
Dharmawardhane S; Hernandez E; Vlaar C
Enzymes; 2013; 33 Pt A(Pt A):117-46. PubMed ID: 25033803
[TBL] [Abstract][Full Text] [Related]
5. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.
Montalvo-Ortiz BL; Castillo-Pichardo L; Hernández E; Humphries-Bickley T; De la Mota-Peynado A; Cubano LA; Vlaar CP; Dharmawardhane S
J Biol Chem; 2012 Apr; 287(16):13228-38. PubMed ID: 22383527
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer.
Velázquez-Vega LE; Rivera-Robles M; Sánchez-Álvarez AO; Vivas-Mejía PE; Aponte-Reyes M; Cruz-Collazo AM; Grafals-Ruiz N; Dorta-Estremera S; Hernández-O'Farrill E; Vlaar CP; Dharmawardhane S
Transl Oncol; 2024 Jun; 44():101928. PubMed ID: 38489873
[TBL] [Abstract][Full Text] [Related]
7. A Rac/Cdc42-specific exchange factor, GEFT, induces cell proliferation, transformation, and migration.
Guo X; Stafford LJ; Bryan B; Xia C; Ma W; Wu X; Liu D; Songyang Z; Liu M
J Biol Chem; 2003 Apr; 278(15):13207-15. PubMed ID: 12547822
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.
Cruz-Collazo A; Ruiz-Calderon JF; Picon H; Borrero-Garcia LD; Lopez I; Castillo-Pichardo L; Del Mar Maldonado M; Duconge J; Medina JI; Bayro MJ; Hernández-O'Farrill E; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2021 Dec; 20(12):2420-2432. PubMed ID: 34607932
[TBL] [Abstract][Full Text] [Related]
9. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
10. The Cool-2/alpha-Pix protein mediates a Cdc42-Rac signaling cascade.
Baird D; Feng Q; Cerione RA
Curr Biol; 2005 Jan; 15(1):1-10. PubMed ID: 15649357
[TBL] [Abstract][Full Text] [Related]
11. Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via alpha-PIX.
Filipenko NR; Attwell S; Roskelley C; Dedhar S
Oncogene; 2005 Sep; 24(38):5837-49. PubMed ID: 15897874
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cdc42 with the anticancer compound MBQ-167 inhibits cell polarity and growth in the budding yeast S. cerevisiae.
Rivera-Robles MJ; Medina-Velázquez J; Asencio-Torres GM; González-Crespo S; Rymond BC; Rodríguez-Medina J; Dharmawardhane S
Small GTPases; 2020 Nov; 11(6):430-440. PubMed ID: 29969362
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for PAK activation by Rac GTPases.
Knaus UG; Wang Y; Reilly AM; Warnock D; Jackson JH
J Biol Chem; 1998 Aug; 273(34):21512-8. PubMed ID: 9705280
[TBL] [Abstract][Full Text] [Related]
14. Targeting Rac and Cdc42 GEFs in Metastatic Cancer.
Maldonado MDM; Medina JI; Velazquez L; Dharmawardhane S
Front Cell Dev Biol; 2020; 8():201. PubMed ID: 32322580
[TBL] [Abstract][Full Text] [Related]
15. Guanine nucleotide exchange factors regulate specificity of downstream signaling from Rac and Cdc42.
Zhou K; Wang Y; Gorski JL; Nomura N; Collard J; Bokoch GM
J Biol Chem; 1998 Jul; 273(27):16782-6. PubMed ID: 9642235
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
Azios NG; Krishnamoorthy L; Harris M; Cubano LA; Cammer M; Dharmawardhane SF
Neoplasia; 2007 Feb; 9(2):147-58. PubMed ID: 17356711
[TBL] [Abstract][Full Text] [Related]
17. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.
Fortin SP; Ennis MJ; Schumacher CA; Zylstra-Diegel CR; Williams BO; Ross JT; Winkles JA; Loftus JC; Symons MH; Tran NL
Mol Cancer Res; 2012 Jul; 10(7):958-68. PubMed ID: 22571869
[TBL] [Abstract][Full Text] [Related]
18. Vav2 as a Rac-GDP/GTP exchange factor responsible for the nectin-induced, c-Src- and Cdc42-mediated activation of Rac.
Kawakatsu T; Ogita H; Fukuhara T; Fukuyama T; Minami Y; Shimizu K; Takai Y
J Biol Chem; 2005 Feb; 280(6):4940-7. PubMed ID: 15485841
[TBL] [Abstract][Full Text] [Related]
19. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
20. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways.
Lim L; Manser E; Leung T; Hall C
Eur J Biochem; 1996 Dec; 242(2):171-85. PubMed ID: 8973630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
